Dr. Sarah Al-Obaydi, MD

Dr. Al-Obaydi practices at BayCare St. Anthony's Hospital in Saint Petersburg, Florida, part of BayCare Health System.

Dr. Al-Obaydi's NPI, 1861924995, was assigned on March 29, 2017. Dr. Al-Obaydi graduated from University of Baghdad College of Medicine in 2008. Dr. Al-Obaydi's Pennsylvania license number on file is MD472200.

Dr. Al-Obaydi's primary practice is BayCare St. Anthony's Hospital, at 1200 Seventh Ave N, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 825-1100.

Dr. Al-Obaydi's primary practice is BayCare St. Anthony's Hospital in Saint Petersburg, Florida, part of BayCare Health System. Dr. Al-Obaydi is also affiliated with Penn State Health Holy Spirit Medical Center. The medical group on file is Professional Health Care of Pinellas. Dmand AI also links Dr. Al-Obaydi to 1 more hospital, 3 medical groups, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Obaydi practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Al-Obaydi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Al-Obaydi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Al-Obaydi's licenses on file in 2 states: Pennsylvania and Florida.

Dmand AI lists acute diabetes, acute respiratory failure, bone infection, cardiac arrhythmia, congestive heart failure, gastrointestinal bleeding, heart attack and pneumonia and respiratory infection among the conditions Dr. Al-Obaydi treats.

CMS data shows 266 Medicare services from Dr. Al-Obaydi across 5 procedure codes in 2024, for 94 Medicare patients. Medicare paid $18,130 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Al-Obaydi in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Obaydi's median patient age at 65, with 47% women.

In 2024, Dr. Al-Obaydi wrote 59 Medicare Part D claims for 39 patients. 86% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Al-Obaydi for performance year 2024, reported as part of a group. Dr. Al-Obaydi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Al-Obaydi, published from 2014 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Drug Hypersensitivity, Hypersensitivity and Anti-Bacterial Agents. Dr. Al-Obaydi has published most often in J Allergy Clin Immunol Pract. Dr. Al-Obaydi's most frequent co-authors are Taha Al-Shaikhly, MBCHB, Timothy J. Craig, DO and James D. Demaio, MD.

Dr. Al-Obaydi graduated from University of Baghdad College of Medicine in 2008.

Dr. Al-Obaydi is in network with 5 carriers, including Elevance, Aetna and Capital Blue Cross. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.